Drawing for MAVUPHARMA

USPTO serial 88143556

MAVUPHARMA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BEAUDRY-TORRES, FAITH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAVUPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cheryl A. Withycombe

Cheryl A. Withycombe AbbVie Inc.1 N. Waukegan Rd.Dept. V377, Bldg. AP34-2North Chicago, IL 60064

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of cancer and infectious diseasesACTIVE—
042Pharmaceutical research and development; consulting services in the fields of pharmaceutical research and development; conducting scientific research and clinical trials for others relating to pharmaceuticals for the prevention and treatment of cancer and infectious diseases; research and development of pharmaceuticals for the prevention and treatment of cancer and infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 26, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 26, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 10, 2020DOCKASSIGNED TO EXAMINER—
Nov 15, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 14, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 12, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 12, 2019EXT1SOU EXTENSION 1 FILED—
Nov 12, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 7, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 21, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 15, 2019ALIEASSIGNED TO LIE—
Jan 30, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jan 30, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 30, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 30, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 15, 2019DOCKASSIGNED TO EXAMINER—
Oct 16, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 8, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance